These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9176883)

  • 1. Molecular genetic events in the development and progression of ovarian cancer in humans.
    Chuaqui RF; Zhuang Z; Merino MJ
    Mol Med Today; 1997 May; 3(5):207-13. PubMed ID: 9176883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology and molecular biology of ovarian epithelial tumors.
    Chuaqui RF; Cole KA; Emmert-Buck MR; Merino MJ
    Ann Diagn Pathol; 1998 Jun; 2(3):195-207. PubMed ID: 9845739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of familial breast-ovarian cancer.
    van Rensburg EJ; Ponder BA
    J Clin Pathol; 1995 Sep; 48(9):789-95. PubMed ID: 7490308
    [No Abstract]   [Full Text] [Related]  

  • 4. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of ovarian cancers.
    Berchuck A; Elbendary A; Havrilesky L; Rodriguez GC; Bast RC
    J Soc Gynecol Investig; 1994; 1(3):181-90. PubMed ID: 9419769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.
    Zelada-Hedman M; Torroella M; Mesquita R; Nordenskjöld M; Skoog L; Lindblom A
    Hum Genet; 1994 Sep; 94(3):231-4. PubMed ID: 8076936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial breast cancer. BRCA1 down, BRCA2 to go.
    Black D
    Curr Biol; 1994 Nov; 4(11):1023-4. PubMed ID: 7874485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
    Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
    Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial breast-ovarian cancer locus on chromosome 17q12-q23.
    Narod SA; Feunteun J; Lynch HT; Watson P; Conway T; Lynch J; Lenoir GM
    Lancet; 1991 Jul; 338(8759):82-3. PubMed ID: 1676470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular abnormalities in epithelial ovarian tumors: present and future].
    Vaurs-Barrière C; Penault-Llorca F
    Bull Cancer; 2001 Aug; 88(8):741-51. PubMed ID: 11578942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
    Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
    J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.
    Smith SA; Easton DF; Evans DG; Ponder BA
    Nat Genet; 1992 Oct; 2(2):128-31. PubMed ID: 1303261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.
    Rodabaugh KJ; Biggs RB; Qureshi JA; Barrett AJ; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1995 Oct; 11(7):1249-54. PubMed ID: 7478544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
    Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
    J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.
    Shih IeM; Kurman RJ
    Clin Cancer Res; 2005 Oct; 11(20):7273-9. PubMed ID: 16243797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers.
    Peng H; Xu F; Pershad R; Hunt KK; Frazier ML; Berchuck A; Gray JW; Hogg D; Bast RC; Yu Y
    Int J Cancer; 2000 Jun; 86(5):690-4. PubMed ID: 10797292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
    Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
    Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.